Appropriate device selection for transcatheter atrial septal defect closure using three-dimensional transesophageal echocardiography.
Adolescent
Adult
Aged
Aged, 80 and over
Cardiac Catheterization
/ adverse effects
Child
Clinical Decision-Making
Echocardiography, Three-Dimensional
Echocardiography, Transesophageal
Female
Heart Septal Defects, Atrial
/ diagnostic imaging
Humans
Male
Middle Aged
Predictive Value of Tests
Prosthesis Design
Retrospective Studies
Septal Occluder Device
Treatment Outcome
Young Adult
Atrial septal defect
Device size
Three-dimensional transesophageal echocardiography
Transcatheter closure
Journal
The international journal of cardiovascular imaging
ISSN: 1875-8312
Titre abrégé: Int J Cardiovasc Imaging
Pays: United States
ID NLM: 100969716
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
25
08
2020
accepted:
30
10
2020
pubmed:
6
11
2020
medline:
6
7
2021
entrez:
5
11
2020
Statut:
ppublish
Résumé
Detail morphological evaluation for ASD is essential to achieve successful transcatheter closure. Three-dimensional transesophageal echocardiography (3D-TEE) is emerging, but few studies have comprehensively verified the usefulness of 3D-TEE. We divided 329 patients who underwent transcatheter ASD closure at our university hospital into 157 in the Conventional group evaluated with 2-dimensional transesophageal echocardiography and balloon sizing (BS), and 172 in the 3D-TEE group evaluated with 3D-TEE additionally. We assessed usefulness of 3D-TEE and consider appropriate device selection procedure. Overall, the percentage with re-sizing of device tended to be lower in the 3D-TEE group than in the Conventional group (10.1% vs 6.0%, p = 0.187). Among preprocedural modalities, the device size was mainly decided based on the BS diameter. A logistic regression analysis demonstrated that large atrial septum aneurysms (ASA) were associated with a ≥ 2 mm discrepancy of the BS diameter from the preprocedural 3D-TEE diameter (p < 0.05). Compared to the Amplatzer Septal Occluder, the differences in device size and the preprocedural ASD measurement were greater when using the Occlutech Figulla Flex II Occluder (FFII). Particularly, among the patients implanted with FFIIs, the discrepancies of the device size from the 3D-TEE measurement were greater in patients with large ASA than those with small ASA. Preprocedural 3D-TEE is useful to select the appropriate device size. Particularly, it is necessary to select a much larger device than that derived from the preprocedural 3D-TEE measurement when using FFII in patients with a septal aneurysm.
Identifiants
pubmed: 33151513
doi: 10.1007/s10554-020-02095-x
pii: 10.1007/s10554-020-02095-x
doi:
Types de publication
Journal Article
Video-Audio Media
Langues
eng
Sous-ensembles de citation
IM
Pagination
1159-1168Références
Oster M, Bhatt AB, Zaragoza-Macias E, Dendukuri N, Marelli A (2019) Interventional therapy versus medical therapy for secundum atrial septal defect: a systematic review (part 2) for the 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 73:1579–1595
doi: 10.1016/j.jacc.2018.08.1032
Stout Karen K, Daniels Curt J, Aboulhosn Jamil A, Bozkurt B, Broberg Craig S, Colman Jack M, Crumb Stephen R, Dearani Joseph A, Fuller S, Gurvitz M et al (2019) 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation 139:e698–e800
pubmed: 30586767
Alnasser S, Lee D, Austin PC, Labos C, Osten M, Lightfoot DT, Kutty S, Shah A, Meier L, Benson L et al (2018) Long term outcomes among adults post transcatheter atrial septal defect closure: Systematic review and meta-analysis. Int J Cardiol 270:126–132
doi: 10.1016/j.ijcard.2018.06.076
Mylotte D, Quenneville SP, Kotowycz MA, Xie X, Brophy JM, Ionescu-Ittu R, Martucci G, Pilote L, Therrien J, Marelli AJ (2014) Long-term cost-effectiveness of transcatheter versus surgical closure of secundum atrial septal defect in adults. Int J Cardiol 172:109–114
doi: 10.1016/j.ijcard.2013.12.144
Wang JK, Tsai SK, Lin SM, Chiu SN, Lin MT, Wu MH (2008) Transcatheter closure of atrial septal defect without balloon sizing. Catheter Cardiovasc Interv 71:214–221
doi: 10.1002/ccd.21308
Gupta SK, Sivasankaran S, Bijulal S, Tharakan JM, Harikrishnan S, Ajit K (2011) Trans-catheter closure of atrial septal defect: balloon sizing or no Balloon sizing - single centre experience. Ann Pediatr Cardiol 4:28–33
doi: 10.4103/0974-2069.79619
Jang JY, Heo R, Cho MS, Bae J, Hong JA, Lee S, Ahn JM, Park DW, Kim DH, Kang DH et al (2018) Efficacy of 3D transoesophageal echocardiography for transcatheter device closure of atrial septal defect without balloon sizing. Eur Heart J Cardiovasc Imaging 19:684–689
doi: 10.1093/ehjci/jex153
Alsaileek AA, Omran A, Godman M, Najm HK (2007) Echocardiographic visualization of laceration of atrial septum during balloon sizing of atrial septal defect. Eur J Echocardiogr 8:155–157
doi: 10.1016/j.euje.2005.12.013
Hascoet S, Hadeed K, Marchal P, Dulac Y, Alacoque X, Heitz F, Acar P (2015) The relation between atrial septal defect shape, diameter, and area using three-dimensional transoesophageal echocardiography and balloon sizing during percutaneous closure in children. Eur Heart J Cardiovasc Imaging 16:747–755
doi: 10.1093/ehjci/jeu316
Seo JS, Song JM, Kim YH, Park DW, Lee SW, Kim WJ, Kim DH, Kang DH, Song JK (2012) Effect of atrial septal defect shape evaluated using three-dimensional transesophageal echocardiography on size measurements for percutaneous closure. J Am Soc Echocardiogr 25:1031–1040
doi: 10.1016/j.echo.2012.07.017
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP, Lung B, Kluin J, Lang IM, Meijboom F et al (2020) 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. https://doi.org/10.1093/eurheartj/ehaa554
doi: 10.1093/eurheartj/ehaa554
pubmed: 33184662
Johri AM, Witzke C, Solis J, Palacios IF, Inglessis I, Picard MH, Passeri JJ (2011) Real-time three-dimensional transesophageal echocardiography in patients with secundum atrial septal defects: outcomes following transcatheter closure. J Am Soc Echocardiogr 24:431–437
doi: 10.1016/j.echo.2010.12.011
Sadiq N, Ullah M, Sultan M, Akhtar K (2014) Transthoracic echocardiography as a measuring and guiding tool for transcatheter device closure of secundum atrial septal defect in young children. J Invasive Cardiol 26:245–248
pubmed: 24907079
Shimizu S, Kawamura A, Arai T, Ohno Y, Mogi S, Kodaira M, Anzai A, Kawakami T, Kanazawa H, Hayashida K et al (2013) Intracardiac echocardiography for percutaneous closure of atrial septal defects: initial experiences in Japan. Cardiovasc Interv Ther 28:368–373
doi: 10.1007/s12928-013-0187-7
Takaya Y, Akagi T, Kijima Y, Nakagawa K, Sano S, Ito H (2015) Long-term outcome after transcatheter closure of atrial septal defect in older patients: impact of age at procedure. JACC Cardiovasc Interv 8:600–606
doi: 10.1016/j.jcin.2015.02.002
Thanopoulos BD, Laskari CV, Tsaousis GS, Zarayelyan A, Vekiou A, Papadopoulos GS (1998) Closure of atrial septal defects with the amplatzer occlusion device: preliminary results. J Am Coll Cardiol 31:1110–1116
doi: 10.1016/S0735-1097(98)00039-4
Haas NA, Happel CM, Soetemann DB, Hanslik A, Moysich A, Kececioglu D, Laser KT (2016) Optimal septum alignment of the Figulla Flex occluder to the atrial septum in patients with secundum atrial septal defects. EuroIntervention 11:1153–1160
doi: 10.4244/EIJY14M12_09
Kenny D, Eicken A, Dahnert I, Boudjemline Y, Sievert H, Schneider MB, Gori T, Hijazi ZM (2019) A randomized, controlled, multi-center trial of the efficacy and safety of the Occlutech Figulla Flex-II Occluder compared to the Amplatzer Septal Occluder for transcatheter closure of secundum atrial septal defects. Catheter Cardiovasc Interv 93:316–321
doi: 10.1002/ccd.27899
Amin Z (2014) Echocardiographic predictors of cardiac erosion after Amplatzer septal occluder placement. Catheter Cardiovasc Interv 83:84–92
doi: 10.1002/ccd.25175
Thanopoulos BD, Dardas P, Ninios V, Eleftherakis N, Karanasios E (2013) Transcatheter closure of large atrial septal defects with deficient aortic or posterior rims using the “Greek maneuver”. A multicenter study. Int J Cardiol 168:3643–3646
doi: 10.1016/j.ijcard.2013.05.011
McElhinney DB, Quartermain MD, Kenny D, Alboliras E, Amin Z (2016) Relative risk factors for cardiac erosion following transcatheter closure of atrial septal defects: a case–control study. Circulation 133:1738–1746
doi: 10.1161/CIRCULATIONAHA.115.019987
Kijima Y, Akagi T, Takaya Y, Taniguchi M, Nakagawa K, Kusano K, Sano S, Ito H (2016) Deficient surrounding rims in patients undergoing transcatheter atrial septal defect closure. J Am Soc Echocardiogr 29:768–776
doi: 10.1016/j.echo.2016.04.010
Moore J, Hegde S, El-Said H, Beekman R, Benson L, Bergersen L, Holzer R, Jenkins K, Ringel R, Rome J et al (2013) Transcatheter device closure of atrial septal defects a safety review. JACC Cardiovasc Interv 6:433–442
doi: 10.1016/j.jcin.2013.02.005
Ferreira SM, Ho SY, Anderson RH (1992) Morphological study of defects of the atrial septum within the oval fossa: implications for transcatheter closure of left-to-right shunt. Br Heart J 67:316–320
doi: 10.1136/hrt.67.4.316
Boon I, Vertongen K, Paelinck BP, Demulier L, Van Berendoncks A, De Maeyer C, Marchau F, Panzer J, Vandekerckhove K, De Wolf D (2018) How to size ASDs for percutaneous closure. Pediatr Cardiol 39:168–175
doi: 10.1007/s00246-017-1743-1
Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, Song JM, Kang DH, Kwon SU, Kang DW et al (2018) Cryptogenic stroke and high-risk patent foramen ovale: The DEFENSE-PFO Trial. J Am Coll Cardiol 71:2335–2342
doi: 10.1016/j.jacc.2018.02.046
Lee JY, Song JK, Song JM, Kang DH, Yun SC, Kang DW, Kwon SU, Kim JS (2010) Association between anatomic features of atrial septal abnormalities obtained by omni-plane transesophageal echocardiography and stroke recurrence in cryptogenic stroke patients with patent foramen ovale. Am J Cardiol 106:129–134
doi: 10.1016/j.amjcard.2010.02.025